APA (7th ed.) Citation

SJ, P., AQ, Q., EL, G., DB, H., & NN, M. (2016). Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes. Current diabetes reports, 16(10), 91. https://doi.org/10.1007/s11892-016-0792-9

Chicago Style (17th ed.) Citation

SJ, Pilla, Quan AQ, Germain-Lee EL, Hellmann DB, and Mathioudakis NN. "Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes." Current Diabetes Reports 16, no. 10 (2016): 91. https://doi.org/10.1007/s11892-016-0792-9.

MLA (9th ed.) Citation

SJ, Pilla, et al. "Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes." Current Diabetes Reports, vol. 16, no. 10, 2016, p. 91, https://doi.org/10.1007/s11892-016-0792-9.